company background image
AXDX

Accelerate Diagnostics NasdaqCM:AXDX Stock Report

Last Price

US$0.83

Market Cap

US$81.8m

7D

-12.7%

1Y

-83.5%

Updated

01 Dec, 2022

Data

Company Financials +
AXDX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health1/6
Dividends0/6

AXDX Stock Overview

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East.

Accelerate Diagnostics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Accelerate Diagnostics
Historical stock prices
Current Share PriceUS$0.83
52 Week HighUS$5.59
52 Week LowUS$0.50
Beta1.24
1 Month Change-32.86%
3 Month Change-49.34%
1 Year Change-83.52%
3 Year Change-94.68%
5 Year Change-97.07%
Change since IPO416.13%

Recent News & Updates

Accelerate Diagnostics spikes as Chief Technology Officer raises stake

Aug 30

Recent updates

Need To Know: Analysts Are Much More Bullish On Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

Aug 20
Need To Know: Analysts Are Much More Bullish On Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

Need To Know: The Consensus Just Cut Its Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Estimates For 2022

Mar 15
Need To Know: The Consensus Just Cut Its Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Estimates For 2022

Should You Take Comfort From Insider Transactions At Accelerate Diagnostics, Inc. (NASDAQ:AXDX)?

Feb 20
Should You Take Comfort From Insider Transactions At Accelerate Diagnostics, Inc. (NASDAQ:AXDX)?

Reflecting on Accelerate Diagnostics' (NASDAQ:AXDX) Share Price Returns Over The Last Three Years

Dec 29
Reflecting on Accelerate Diagnostics' (NASDAQ:AXDX) Share Price Returns Over The Last Three Years

Shareholder Returns

AXDXUS Medical EquipmentUS Market
7D-12.7%3.0%1.4%
1Y-83.5%-17.4%-16.1%

Return vs Industry: AXDX underperformed the US Medical Equipment industry which returned -16.8% over the past year.

Return vs Market: AXDX underperformed the US Market which returned -14.8% over the past year.

Price Volatility

Is AXDX's price volatile compared to industry and market?
AXDX volatility
AXDX Average Weekly Movement17.9%
Medical Equipment Industry Average Movement8.9%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: AXDX is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 18% a week.

Volatility Over Time: AXDX's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1982220Jack Phillipshttps://acceleratediagnostics.com

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk.

Accelerate Diagnostics, Inc. Fundamentals Summary

How do Accelerate Diagnostics's earnings and revenue compare to its market cap?
AXDX fundamental statistics
Market CapUS$81.84m
Earnings (TTM)-US$70.50m
Revenue (TTM)US$13.12m

6.2x

P/S Ratio

-1.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AXDX income statement (TTM)
RevenueUS$13.12m
Cost of RevenueUS$13.79m
Gross Profit-US$665.00k
Other ExpensesUS$69.83m
Earnings-US$70.50m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.71
Gross Margin-5.07%
Net Profit Margin-537.19%
Debt/Equity Ratio-742.1%

How did AXDX perform over the long term?

See historical performance and comparison